Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is highly rated in 48 conditions, according to our data. His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is highly rated in 27 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is highly rated in 25 conditions, according to our data. His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is highly rated in 23 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 15 conditions, according to our data. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, Malignant Mixed Mullerian Tumor, and Salpingo-Oophorectomy.

Kevin Holcomb is an Oncologist in New Hyde Park, New York. Dr. Holcomb is highly rated in 12 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Salpingo-Oophorectomy, and Lymphadenectomy.

Richard Carvajal is an Oncologist in Lake Success, New York. Dr. Carvajal is highly rated in 9 conditions, according to our data. His top areas of expertise are Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy.

The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is highly rated in 7 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.

Joan Tymon is an Oncologist in New Hyde Park, New York. Dr. Tymon is highly rated in 7 conditions, according to our data. Her top areas of expertise are Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, and Sertoli-Leydig Cell Tumor.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is highly rated in 33 conditions, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is highly rated in 33 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Colorectal Cancer.

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is highly rated in 25 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is highly rated in 23 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is highly rated in 22 conditions, according to our data. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Michael J. Schwartz, MD, is Chief of Urology at Long Island Jewish Medical Center and Director of Urology Services for Northwell Health's Central Region. Dr. Schwartz specializes in minimally invasive procedures to treat prostate cancer. He has vast experience in robotic-assisted radical prostatectomy, evolving surgical techniques over time to minimize treatment-related side effects. For qualifying prostate cancer patients, Dr. Schwartz also offers focal ablation therapies, using sophisticated image guidance and focal tissue ablation to eradicate prostate cancer with few side effects. He has additional expertise in urologic oncology and surgery to treat kidney, bladder, adrenal and testicular cancers. Becoming a doctor always felt natural to me, Dr. Schwartz says. I was always interested in helping others, and urology is a wonderful blend of both medical and surgical care, allowing for the development of long-term relationships with my patients. Dr. Schwartz earned his medical degree from Warren Alpert Medical School of Brown University and pursued his residency training in urology at New York-Presbyterian Hospital, Cornell. He received his fellowship training in advanced laparoscopic and endoscopic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Dr. Schwartz values a team-based approach to care, working with radiologists, pathologists and medical oncologists to create individualized, evidence-based treatment plans. He also carefully listens to patients to meet their unique goals and preferences. In addition to treating prostate cancer, Dr. Schwartz is a pioneer in prostate cancer diagnosis. He was an early adopter of transperineal biopsy-which eliminates the infection risk associated with the prior transrectal method-and helped the Smith Institute of Urology transition to using that approach for all patients requiring prostate biopsy across Northwell Health. His research focuses on both diagnostics and treatment of prostate cancer, and he is involved with several clinical trials for focal therapy. He is a member of the American Urological Association and Society of Urologic Oncology. He is Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. For Dr. Schwartz, one of the best parts of his job is getting to know his patients. I have the privilege of seeing their humanity, learning about their lives and discovering what's important to them, he says. Their experiences inspire me every day. Dr. Schwartz is highly rated in 19 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Nephrectomy.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is highly rated in 16 conditions, according to our data. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

"Andrew Menzin, MD, is an OB/GYN and oncology specialist at Northwell Health Physician Partners Gynecologic Oncology at New Hyde Park. He is also the chief of gynecologic oncology for Northwell facilities across central Long Island and Queens, and the vice chairman of academic affairs for the OB/GYN service line. Dr. Menzin has nearly three decades of experience in gynecologic oncology and academic medicine.""I come from a family of doctors,"" he says. ""Education, medicine and service to others was just part of how I grew up.""Dr. Menzin treats the full spectrum of gynecologic issues, from benign conditions to all malignancies of the female reproductive system. His extensive surgical expertise includes cancer surgery, robotic surgery and complex gynecologic surgery.He joined Northwell Health in 1995, after completing a fellowship in gynecologic oncology and a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania.""At Northwell, we're here to meet every patient's needs and deliver truly collaborative care,"" says Dr. Menzin, who works closely with specialists including pathologists, radiologists, medical oncologists, radiation oncologists, general surgeons, colorectal surgeons and urologists. He carefully explains this multifaceted care to each patient-even drawing his unique diagrams for extra clarity.Dr. Menzin is a professor of obstetrics and gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a member of the Society of Gynecologic Oncology, as well as a fellow of the American College of Surgeons and the American College of Obstetricians and Gynecologists. He's been named numerous times on the Castle Connolly Top Doctors list, and he's an avid supporter of the National Ovarian Cancer Coalition, which supports ovarian cancer survivors and funds research to find a cure.""I have had great mentors who've inspired me along the way,"" says Dr. Menzin. ""It's all about delivering care that's patient-centered. Looking after them the way I'd want to be cared for.""". Dr. Menzin is highly rated in 15 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Salpingo-Oophorectomy.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is highly rated in 14 conditions, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Kit Cheng, MD, is the Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she is committed to the recruitment and education of future generations of physicians. Board certified in Internal Medicine, Hematology and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As an attending physician based at the Monter Cancer Center, Dr. Cheng specializes in breast cancer and gynecology oncology, namely cervical cancer, endometrial cancer, ovarian cancer, uterine cancer and vaginal cancer. She is a principal investigator and sub principal investigator in multiple breast and gynecologic oncology clinical trials. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Cheng earned her medical degree at the State University of New York at Buffalo. She trained in Internal Medicine and Hematology/Oncology at North Shore University Hospital where she was also Chief Fellow. Dr. Cheng is an active member of the American Society of Clinical Oncology and is fluent in Cantonese and English. Dr. Cheng is highly rated in 13 conditions, according to our data. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Jill Whyte is an Oncologist in New Hyde Park, New York. Dr. Whyte is highly rated in 12 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Adult Soft Tissue Sarcoma, Salpingo-Oophorectomy, and Gastrostomy.

Malvina Fulman, MD, is a medical oncologist and hematologist with an interest in breast cancer. She practices at Northwell Health Cancer Institute Queens Medical Associates, a group of eight oncologists and a palliative care doctor. The doctors and staff within this group speak more than 10 languages, which helps them to accommodate the cultural diversity of Queens. Dr. Fulman speaks Russian, Georgian and English.The idea behind our group is to help our patients in the best possible way, Dr. Fulman says. It's much easier when you can relate to your doctor in the same language. We understand not only the medical part. We also understand the cultural part, so we can address those issues as well.Dr. Fulman was inspired to become a doctor after an aunt died of breast cancer when Dr. Fulman was 14. You want to help your family and to help other people as well, she says.After finishing her medical education at Tbilisi State Medical Institute in Georgia, she completed an internship at Republican Hospital in Tbilisi, Georgia, and a residency and fellowship at Cabrini Medical Center/ Mount Sinai School of Medicine.Dr. Fulman is board certified in medical oncology and hematology. She is also a Fellow of the American College of Physicians and belongs to the American Society of Clinical Oncology, and she has a teaching appointment at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.One of the best parts of Dr. Fulman's job is seeing her patients reach milestones with their families graduations, weddings, and anniversaries. I enjoy when I go to work and see patients who came to me five, 10, 15, 20 years ago, and they're still around and they're still okay, Dr. Fulman says. It's really special. Dr. Fulman is highly rated in 10 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Polycythemia Vera.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is highly rated in 10 conditions, according to our data. Her top areas of expertise are Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Dr. Irina Murakhovskaya is an Assistant Professor of Medicine (Hematology). She completed a medical degree at Albert Einstein College of Medicine and residency and fellowship training at Montefiore Health System. Her clinical interests focus on monoclonal gammopathy, low-grade lymphoma, and hematologic issues in pregnancy. Dr. Murakhovskaya is highly rated in 10 conditions, according to our data. Her top areas of expertise are Autoimmune Hemolytic Anemia, Thrombocytopenia, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is highly rated in 9 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Dennis Kuo is an Oncologist in Flushing, New York. Dr. Kuo is highly rated in 8 conditions, according to our data. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor.